Skip to content

ProShares Ultra Health Care

RXLNYSE ArcaBThis fund multiplies its index's move each day and resets that multiple daily. Because daily returns compound, its long-run return can differ from the headline multiple.

$59.38−1.55 (−2.54%)

As of Oct 13, 2026, 3:59 PM

Intraday session: down, 78 prints from 60.93 to 59.38. Range 59.27 to 61.01. Use the arrow keys to read each point.60.0060.5010 AM12 PM2 PM4 PM
Expense ratio
1.07%
Fund size
$97M
1Y total return
+39.8%
Yield · Last 12 months
1.04%
Holdings
62
Avg volume · 30D
0M sh
NAV per share
$60.98
52W range
low $42.76high $64.60
Launched
Filings
SEC EDGAR

The ETF.net RXL Grade

Based on 5 of 6 pillars

B

Score 56 out of 100

Rank
16 of 99
Six-pillar profile for RXL. Scores out of 100: Cost 44, Risk 66, Mission not scored, Tradability 64, Holdings 54, Durability 75. Strongest: Durability (75). Weakest: Cost (44). Based on 5 of 6 pillars.

Score 56 of 100 falls in the B band. A is 70 or higher, B 55 to under 70, C 40 to under 55, D 25 to under 40, F under 25.

  • Cost

    The fund’s net expense ratio, ranked against its category.
    C44 out of 100
    Rank 55 of 99
  • Mission

    Whether the fund did what it promised, tested against its stated mandate.
    Not scored
  • Risk

    How the fund held up when markets fell: downside volatility, drawdowns and tail loss.
    B66 out of 100
    Rank 19 of 96
  • Tradability

    How easy the fund is to trade: daily volume, and how far its price strays from net asset value.
    B64 out of 100
    Rank 26 of 99
  • Holdings

    How concentrated the fund is, and how complete and current its disclosed holdings are.
    C54 out of 100
    Rank 12 of 23
  • Durability

    Whether the fund is likely to stay open, judged by its age, its assets and its issuer’s assets.
    A75 out of 100
    Rank 11 of 99

Our read on RXL

ETF.net Research

BThe 2x way to lean on health care. RXL doubles the daily move of the big health care sector index, roughly 70 drug, device and insurer names, and it has been doing that since 2007. The leverage resets every day.

Stated mandate

The fund seeks daily returns, before fees and expenses, equal to two times the daily performance of the S&P Health Care Select Sector Index.

Why people hold it

  1. 01Aims for two times the daily performance of the S&P Health Care Select Sector Index: about 70 pharma, device and insurer stocks, not a single-name bet.proshares.com
  2. 02Double, not triple. The 2x mandate applies the same daily-reset machinery with less daily punch than 3x sector products.proshares.com
  3. 03Running since 2007, so the structure has operated through the financial crisis, COVID and several drug-pricing scares. Long tenure for a leveraged fund.
  4. 04Pays on a quarterly schedule, which is unusual company for a geared sector fund.

Worth knowing

  1. 01The 2x target is a daily one. Hold longer and compounding takes over: in choppy stretches, results can diverge meaningfully from twice the index move.
  2. 02A small fund that trades thinly, so bid-ask spreads can run wider than on the headline leveraged names.
  3. 03The 1.07% expense ratio sits a shade above the typical leveraged bull fund, and cheaper geared products exist on other sectors (FAS 0.92%, UYG 0.94%).

RXL Holdings

As of Oct 13, 2026
Asset class
Stocks
Holdings
62
Top-10 weight
70%
Largest holding
Net Other Assets (Liabilities)17.5%

Sectors

  • Health Care80.3%
  • Financials19.1%
  • Technology0.6%

Geography

  • United States98.28%
  • Ireland1.72%
The fund’s holdings, weight-ordered — page 1 of 5.
#TickerCompanyWeight %SharesMarket valueIn ETFs
001—Net Other Assets (Liabilities)17.48%16,949,154$17M163
002IQMMProshares Genius Mny Mkt Etf15.49%150,000$15M61
003LLYEli Lilly & Co10.17%8,340$10M583
004JNJJohnson & Johnson6.83%25,122$7M528
005ABBVAbbVie Inc5.34%18,418$5M522
006MRKMerck & Co. Inc.3.86%25,716$4M515
007UNHUnitedHealth Group Inc3.65%9,357$4M481
008TMOThermo Fisher Scientific Inc2.63%3,852$3M375
009AMGNAmgen Inc2.43%5,635$2M491
010GILDGilead Sciences Inc2.01%12,925$2M492
011ABTAbbott Laboratories1.89%18,038$2M376
012PFEPfizer Inc1.74%59,412$2M378
013ISRGIntuitive Surgical Inc1.62%3,682$2M410
014DHRDanaher Corp1.49%6,522$1M331
015VRTXVertex Pharmaceuticals Inc1.38%2,644$1M422

Showing 1–15 of 62 holdings

RXL Performance

Launched Jan 30, 2007

Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.

RXL$13,979
SPY tracks large US stocks. It provides market context, rather than representing this fund’s strategy, asset class or investment benchmark.$12,044
Oct 10, 2025 to Oct 12, 2026. RXL $13,979. SPY $12,044. Use the arrow keys to read each point.$9,376$12,199$15,023Oct 2025Apr 2026Oct 2026

Oct 10, 2025 – Oct 12, 2026

Returns run to the Oct 12, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.

Trailing total return for RXL. Periods over one year show the average yearly return.
PeriodRXL
Year to date+18.7%
1 month+8.3%
3 months+12.6%
1 year+39.8%
3 yearsper year+15.0%
5 yearsper year+6.7%
10 yearsper year+15.4%

As of the close, with distributions reinvested.

Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.

Annual total returns for RXL
YearReturn barRXL
2026 YTD+18.7%
2025+19.8%
2024−2.7%
2023−3.2%
2022−15.3%
2021+48.1%
2020+19.2%

RXL in the news

Filtered to RXL · Leveraged Long (2x & Other)

RXL Dividends

Adds up every distribution paid per share over the last 12 months, divided by the last completed close. Distributions are counted by ex-date. Data through Oct 12, 2026.
1.04%Last 12 months
Payout per share
$0.63Last 12 months
Last payment
$0.13 per share
Paid on
Shares bought on or after this date do not qualify for this distribution.
Frequency
Quarterly

Distribution history

2017–2026

One bar per payment. 29 payments from 2017 to 2026 YTD. Dec 26, 2017 $0.03; Mar 21, 2018 $0.02; Jun 20, 2018 $0.01; Sep 26, 2018 $0.01; Dec 26, 2018 $0.03; Mar 20, 2019 $0.03; Jun 25, 2019 $0.02; Dec 24, 2019 $0.03; Mar 25, 2020 $0.04; Dec 23, 2020 $0.02; Mar 23, 2021 $0.02; Jun 22, 2021 $0.0065; Sep 22, 2021 $0.006; Dec 23, 2021 $0.02; Mar 23, 2022 $0.05; Jun 22, 2022 $0.0015; Dec 22, 2022 $0.11; Dec 20, 2023 $0.08; Mar 20, 2024 $0.09; Jun 26, 2024 $0.17; Sep 25, 2024 $0.13; Dec 23, 2024 $0.15; Mar 26, 2025 $0.13; Jun 25, 2025 $0.22; Sep 24, 2025 $0.20; Dec 24, 2025 $0.18; Mar 25, 2026 $0.14; Jun 24, 2026 $0.18; Sep 23, 2026 $0.13. Use the arrow keys to read each point.2017201820192020202120222023202420252026YTD
Ex-datePay dateAmount per share
Sep 23, 2026Sep 29, 2026$0.13
Jun 24, 2026Jun 30, 2026$0.18
Mar 25, 2026Mar 31, 2026$0.14
Dec 24, 2025Dec 31, 2025$0.18
Sep 24, 2025Sep 30, 2025$0.20
Jun 25, 2025Jul 1, 2025$0.22
Mar 26, 2025Apr 1, 2025$0.13
Dec 23, 2024Dec 31, 2024$0.15
Sep 25, 2024Oct 2, 2024$0.13
Jun 26, 2024Jul 3, 2024$0.17
Mar 20, 2024Mar 27, 2024$0.09
Dec 20, 2023Dec 28, 2023$0.08

RXL Risk

This fund targets a multiple of the daily move of its index and resets daily. Hold it longer than one reset and compounding makes the return diverge from that target. In choppy markets it can lose value even when the index ends flat.

How much the fund’s monthly returns vary, scaled to a year.
28.3%
Annualised · 36 months to Sep 2026
How it’s calculated: standard deviation

The sample standard deviation of monthly total returns, multiplied by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.

Return above 3-month US Treasury bills per unit of volatility.
0.45
vs 3-month T-bills · to Sep 2026
How it’s calculated: Sharpe ratio

Subtract each month’s Treasury-bill return from the fund’s monthly total return.

Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.

The largest fall from a peak to the low that followed.
−36.1%
Trough Aug 2025
How it’s calculated: maximum drawdown

The largest percentage decline from an earlier peak, using total returns with reinvested distributions.

Uses up to five years through the last close, with at least 12 months required.

How strongly the fund’s returns move with its asset-class index.
1.14
vs its asset-class index
How it’s calculated: beta

The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.

RXL Cost

Expense ratio1.07%
  • The middle half of Leveraged Long (2x & Other) funds
  • Median 1.00%

54 of the 95 Leveraged Long (2x & Other) funds charge less.

RXL costs $107.00 a year on $10,000. The median Leveraged Long (2x & Other) fund costs $100.00.

Other funds in Leveraged Long (2x & Other)